Loading organizations...
Saratoga Ventures operated as a venture capital firm, dedicating its investments to the life sciences sector. The firm focused on providing capital and strategic guidance to companies innovating within medical devices, healthcare technology, biotechnology, and pharmaceuticals. It aimed to accelerate the development and market entry of promising new solutions across these specialized fields.
Richard M Ferrari founded Saratoga Ventures in 1997, establishing its operations in Mountain View, United States. Ferrari’s insight centered on the critical need for specialized investment and expertise within the rapidly evolving life sciences industry. His vision was to support scientific breakthroughs by leveraging the rich entrepreneurial ecosystem and technological talent of the region.
The firm partnered with companies involved in medical innovation, from early-stage ventures to those nearing commercialization. Saratoga Ventures’ mission was to fuel progress in human health by strategically backing promising scientific and technological endeavors. It sought to contribute to the development of new treatments and solutions, shaping medicine through its investment activities.
Saratoga Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $33.0M Series D in MyoScience in March 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 21, 2012 | MyoScience | $33.0M Series D | — | Accuitive Medical Ventures, American Equities Overseas, DeNovo Ventures, Medicis Capital, Nexus Medical Partners, Valiance |
| Dec 5, 2008 | Broncus Technologies | $38.0M Other Equity | Ares Life Sciences | Abingworth, Bio*one Capital, Broncus Technologies, Charter Ventures, HBM Healthcare Investments, JAIC America, Menlo Ventures, PAC Link Ventures, Resuscitated, Saints Capital, Sightline Ventures |
